Receptors, Antigen, T-Cell

"Receptors, Antigen, T-Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Molecules on the surface of T-lymphocytes that recognize and combine with antigens. The receptors are non-covalently associated with a complex of several polypeptides collectively called CD3 antigens (CD3 COMPLEX). Recognition of foreign antigen and the major histocompatibility complex is accomplished by a single heterodimeric antigen-receptor structure, composed of either alpha-beta (RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA) or gamma-delta (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA) chains.

Descriptor ID	D011948
MeSH Number(s)	D12.776.543.750.705.816.824
Concept/Terms	Receptors, Antigen, T-Cell Receptors, Antigen, T-Cell T-Cell Antigen Receptor Antigen Receptor, T-Cell Receptor, T-Cell Antigen T Cell Antigen Receptor T-Cell Receptors Receptors, T-Cell T Cell Receptors T-Cell Receptor Receptor, T-Cell T Cell Receptor Receptors, T-Cell Antigen Receptors, T Cell Antigen T-Cell Antigen Receptors Antigen Receptors, T-Cell Antigen Receptors, T Cell

Below are MeSH descriptors whose meaning is more general than "Receptors, Antigen, T-Cell".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Membrane Proteins [D12.776.543]
Receptors, Cell Surface [D12.776.543.750]
Receptors, Immunologic [D12.776.543.750.705]
Receptors, Antigen [D12.776.543.750.705.816]
Receptors, Antigen, T-Cell [D12.776.543.750.705.816.824]

Below are MeSH descriptors whose meaning is related to "Receptors, Antigen, T-Cell".

Below are MeSH descriptors whose meaning is more specific than "Receptors, Antigen, T-Cell".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Receptors, Antigen, T-Cell" by people in this website by year, and whether "Receptors, Antigen, T-Cell" was a major or minor topic of these publications.

Bar chart showing 81 publications over 25 distinct years, with a maximum of 8 publications in 2006 and 2008

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	1	0	1
2001	1	1	2
2002	1	2	3
2003	1	0	1
2004	2	5	7
2005	2	3	5
2006	2	6	8
2007	4	3	7
2008	5	3	8
2009	4	0	4
2010	1	5	6
2011	1	0	1
2012	2	1	3
2013	0	1	1
2014	2	1	3
2015	1	1	2
2016	1	2	3
2017	1	1	2
2018	0	1	1
2020	0	1	1
2021	1	1	2
2022	0	4	4
2023	0	3	3
2024	1	1	2
2025	0	1	1

Below are the most recent publications written about "Receptors, Antigen, T-Cell" by people in Profiles.

Golovin AV, Panteleev S, Zlobin AS, Anikeeva N, Smirnov I, Gabibov A, Sykulev Y. The role of peptide conformation presented by MHC in the induction of TCR triggering. Biophys J. 2025 Apr 01; 124(7):1073-1084.

View in: PubMed
Mayadev J, Zamarin D, Deng W, Lankes HA, Pesci G, Kim H, Chino JP, Banbury B, Sherry N, Sharon E, Ghamande SA, Ferguson C, Mell L, Holman L, Mathews C, O'Malley D, Olawaiye A, Hopp E, Leath C, Copeland L, Mannel R, O'Cearbhaill R, Aghajanian C, Schilder RJ. Neoadjuvant or concurrent atezolizumab with chemoradiation for locally advanced cervical cancer: a randomized phase I trial. Nat Commun. 2025 Jan 09; 16(1):553.

View in: PubMed
King Z, Fraint E. Chimeric Antigen Receptor T-Cell Treatment in Children. Pediatr Rev. 2024 May 01; 45(5):301-302.

View in: PubMed
Gao Y, Dong K, Gao Y, Jin X, Yang J, Yan G, Liu Q. Unified cross-modality integration and analysis of T?cell receptors and T?cell transcriptomes by low-resource-aware representation learning. Cell Genom. 2024 May 08; 4(5):100553.

View in: PubMed
Mandel J, Gleason L, Joffe D, Bhatti S, Nikbakht N. Immunosequencing applications in cutaneous T-cell lymphoma. Front Immunol. 2023; 14:1300061.

View in: PubMed
Sykulev Y. Factors contributing to the potency of CD8+ T cells. Trends Immunol. 2023 09; 44(9):693-700.

View in: PubMed
Zipper R, Loeb DM, Lee MA, Oliver-Krasinski J, Liszewski MC, Fraint E. Respiratory Failure Due to Idiopathic Pneumonia Syndrome in a Pediatric Patient After Recipient-derived Allogeneic Chimeric Antigen Receptor T-Cell Therapy. J Pediatr Hematol Oncol. 2023 08 01; 45(6):e775-e780.

View in: PubMed
Pan Y, Phillips JW, Zhang BD, Noguchi M, Kutschera E, McLaughlin J, Nesterenko PA, Mao Z, Bangayan NJ, Wang R, Tran W, Yang HT, Wang Y, Xu Y, Obusan MB, Cheng D, Lee AH, Kadash-Edmondson KE, Champhekar A, Puig-Saus C, Ribas A, Prins RM, Seet CS, Crooks GM, Witte ON, Xing Y. IRIS: Discovery of cancer immunotherapy targets arising from pre-mRNA alternative splicing. Proc Natl Acad Sci U S A. 2023 May 23; 120(21):e2221116120.

View in: PubMed
Yi D, Gergis M, Elgohary G, Hsu J, Yang Y, Bi X, Gergis U. Chimeric Antigen Receptor T-cell Therapies in Lymphoma Patients with Central Nervous System Involvement. Hematol Oncol Stem Cell Ther. 2022 Dec 15; 15(3):66-72.

View in: PubMed
Hsu J, Yang Y, Gergis M, Bi X, Yi D, Gergis U. Chimeric Antigen Receptor T Cell Therapy For Solid Tumors. Hematol Oncol Stem Cell Ther. 2022 Dec 15; 15(3):94-99.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement